Beneficient (NASDAQ:BENF – Get Free Report) released its quarterly earnings results on Monday. The company reported ($1.49) EPS for the quarter, missing the consensus estimate of $0.15 by ($1.64), Zacks reports.
Beneficient Stock Down 0.6%
BENF traded down $0.00 on Monday, hitting $0.62. 51,153 shares of the company traded hands, compared to its average volume of 3,046,668. Beneficient has a 12-month low of $0.50 and a 12-month high of $9.96. The company has a 50 day moving average of $1.03 and a 200-day moving average of $2.85. The stock has a market capitalization of $9.66 million, a PE ratio of -0.09 and a beta of 0.05.
Analysts Set New Price Targets
A number of equities analysts have recently issued reports on BENF shares. Wall Street Zen upgraded shares of Beneficient to a “hold” rating in a research report on Saturday, October 24th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Beneficient in a research report on Monday, September 21st. One equities research analyst has rated the stock with a Sell rating. Based on data from MarketBeat, Beneficient currently has a consensus rating of “Sell”.
Beneficient Company Profile
Beneficient is a financial services company focused on providing liquidity and related services for investors in alternative assets, such as interests in private equity and other private funds. These investments can be difficult to sell, and the company’s services are intended to help holders access liquidity without waiting for a fund’s full life cycle to end. The company offers financing and transaction solutions for alternative-asset holders, alongside trust, custody, and administrative services.
Read More
- Five stocks we like better than Beneficient
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Beneficient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beneficient and related companies with MarketBeat.com's FREE daily email newsletter.
